Presence of retinal pericyte-reactive autoantibodies in diabetic retinopathy patients

Lingjun Zhang, Yan Li, John Payne, Sunil Srivastava, Xingjun Fan, John Fung, Xiaorong Li, Timothy S. Kern, Feng Lin

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


The loss of retinal pericytes (RPCs) is a hallmark of early stage diabetic retinopathy (DR), but the mechanism underlying RPC death is unclear. Although it was postulated in previous studies using bovine RPCs that autoantibodies against RPCs might develop and induce RPC death, it is unknown whether autoantibodies against cell-surface antigens on human RPCs exist in DR patients, whether such autoantibodies contribute to RPC damage/loss, and if they do, through which mechanism. We screened serum samples from DR patients and controls using primary human RPCs and found that that levels of IgGs reactive to RPCs were significantly higher in the DR group than the control group. Serum samples with higher RPC-reactive IgG levels induced more severe complement-mediated RPC damage than those with lower RPC-reactive IgG levels. We also assessed levels of the complement-activation products C3a, C4a and C5a in these serum samples, and found that serum levels of C3a and C5a, but not C4a, were higher in the DR group than control group. These data provide evidence the first time showing that autoantibodies against RPCs can develop in DR patients, and that these autoantibodies could contribute to pericyte damage through complement activation.

Original languageEnglish (US)
Article number20341
JournalScientific reports
StatePublished - Feb 3 2016
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Presence of retinal pericyte-reactive autoantibodies in diabetic retinopathy patients'. Together they form a unique fingerprint.

Cite this